Merck
MRK
#42
Rank
$356.01 B
Marketcap
$144.30
Share price
0.34%
Change (1 day)
61.21%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): $1.27

According to Merck's latest financial reports the company's current EPS (TTM) is $1.27. In 2025 the company made an earnings per share (EPS) of $7.31 an increase over its 2024 EPS that were of $6.76.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$1.27-82.69%
2025$7.318.15%
2024$6.764308.46%
2023$0.15-97.32%
2022$5.7310.92%
2021$5.1784.68%
2020$2.80-27.2%
2019$3.8463.44%
2018$2.35151.11%
2017$0.94-54.58%
2016$2.0630.21%
2015$1.58-61.99%
2014$4.16180.51%
2013$1.48-31.82%
2012$2.186.62%
2011$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$8.73 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$6.66 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$3.12 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$29.88 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$16.22 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.90 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$4.54 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$3.20 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$0.63-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel